Aller au contenu principal
Profil bibliographique

Edlue M. Tabengwa

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

38Publications signalées
938Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Alcohol Consumption and Health EffectsAntiplatelet Therapy and Cardiovascular DiseasesBlood properties and coagulationProtease and Inhibitor MechanismsAcute Ischemic Stroke Management

Les publications récentes

Accès ouvert 2023 article OpenAlex

FCRL1 immunoregulation in B cell development and malignancy

Murali Krishna Mamidi, Jifeng Huang, Kazuhito Honjo, Ran Li et autres

Immunotherapeutic targeting of surface regulatory proteins and pharmacologic inhibition of critical signaling pathways has dramatically shifted our approach to the care of individuals with B cell malignancies. This evolution in therapy reflects the central role of the B cell receptor (BCR) signaling …

us, tw (code pays fourni par la source)

22 citations Frontiers in Immunology
Accès ouvert 2022 article OpenAlex

Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodies

Sarah Sterrett, Lucinda A. Hall, Edlue M. Tabengwa, Kazuhito Honjo et autres

Quantification of the anti-SARS-CoV-2 antibody response has proven to be a prominent diagnostic tool during the COVID-19 pandemic. Antibody measurements have aided in the determination of humoral protection following infection or vaccination and will likely be essential for predicting the prevalence of …

us (code pays fourni par la source)

9 citations Protein Engineering Design and Selection
Accès ouvert 2020 article OpenAlex

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

Kazuhito Honjo, Ronnie M. Russell, Ran Li, Weimin Liu et autres

Convalescent plasma (CP) is widely used to treat COVID-19, but without formal evidence of efficacy. Here, we report the beneficial effects of CP in a severely ill COVID-19 patient with prolonged pneumonia and advanced chronic lymphocytic leukemia (CLL), who was unable to …

us (code pays fourni par la source)

30 citations Cell Reports Medicine
Accès ouvert 2019 article OpenAlex

Fc receptor-like 2 (FCRL2) is a novel marker of low-risk CLL and refines prognostication based on IGHV mutation status

Lauren Kelly Shea, Kazuhito Honjo, David T. Redden, Edlue M. Tabengwa et autres

Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in Western countries and is characterized by a progressive accumulation of CD5 + monoclonal B cells in the blood and bone marrow. The clinical course in CLL is remarkably heterogeneous; the monoclonal population …

us (code pays fourni par la source)

12 citations Blood Cancer Journal
Accès ouvert 2017 article OpenAlex

Differential binding of the HIV-1 envelope to phosphatidylserine receptors

Linlin Gu, Brian Sims, Alexandre Krendelchtchikov, Edlue M. Tabengwa et autres

Prior work has shown that the HIV-1 envelope of the human immunodeficiency virus (HIV) interacts directly with T-cell immunoglobulin mucin (TIM) family proteins. Herein, we demonstrate that HIV-1 envelope glycoproteins from varying HIV-1 clades bind differentially to TIM proteins and functionally similar …

us (code pays fourni par la source)

11 citations Biochimica et Biophysica Acta (BBA) - Biomembranes

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.